Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine

A 62-year-old woman who underwent surgery to treat pancreatic cancer provided written, informed consent to undergo adjuvant therapy with gemcitabine, tegafur, and uracil. However, this was stopped after only 14 days due to Grade 4 neutropenia. She was then started on vaccine therapy with Survivin 2B...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Cancer Immunol Immunother
मुख्य लेखकों: Shima, Hiroaki, Kutomi, Goro, Satomi, Fukino, Imamura, Masafumi, Kimura, Yasutoshi, Mizuguchi, Toru, Watanabe, Kazue, Takahashi, Akari, Murai, Aiko, Tsukahara, Tomohide, Kanaseki, Takayuki, Hirohashi, Yoshihiko, Iwayama, Yuji, Tsuruma, Tetsuhiro, Kameshima, Hidekazu, Sato, Noriyuki, Torigoe, Toshihiko, Takemasa, Ichiro
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Springer Berlin Heidelberg 2018
विषय:
Original Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6182403/
https://ncbi.nlm.nih.gov/pubmed/30069687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-018-2217-x
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन